Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-08-06

FDA Approved: LAMPIT — Original Application (Bayer HealthCare Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves Lampit (nifurtimox) under an original application by Bayer for the treatment of Chagas disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lampit (nifurtimox)

Snippet

ORIG AP for LAMPIT (NIFURTIMOX)